Bundamedik Tbk vs Semen Indonesia (Persero) Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Semen Indonesia (Persero) Tbk. trades at Rp1,450 (market cap 9.72T, 11.28M 24h volume). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 6.4× Bundamedik Tbk's market cap, and Semen Indonesia (Persero) Tbk. is more actively traded (11.28M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | SMGR | |
|---|---|---|
Market Cap | 1.51T | 9.72T |
Volume | 536.7K | 11.28M |
Lot | 5.37K | 112.8K |
Turnover | 93.41M | 16.37B |
Average Price | 174.05 | 1,451.01 |
Value | 93.41M | 16.37B |
Indicative Equilibrium Price | 176 | 1,450 |
Indicative Equilibrium Volume | 100 | 2.71K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →